Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Drospirenone-Ethinyl Estradiol (20µg) in Comparison to Drospirenone-Ethinyl Estradiol (30µg) on Free Androgen Index in Polycystic Ovary Syndrome

NCT07318337 is registered in ClinicalTrials.gov with Mst.Sumyara Khatun as lead sponsor.

NCT NCT07318337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07318337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Drospirenone-Ethinyl Estradiol (20µg) in Comparison to Drospirenone-Ethinyl Estradiol (30µg) on Free Androgen Index in Polycystic Ovary Syndrome
Lead sponsor
Mst.Sumyara Khatun
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2024
Completion date
June 30, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcos (polycystic ovary syndrome)